Tue, Sep 8 04:33 PM

Pharma major Novartis falls 10% after three drug trial setbacks

CNBC•Tue, Sep 8, 2026, 03:29 PM•2 min read

Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.

Source: [CNBC](https://www.cnbc.com/2026/09/08/novartis-novn-del-desiran-drug-trial.html)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

More Headlines

FinanceSeeking Alpha• 7m ago

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 8m ago

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 8m ago

Developing story — details emerging. Check the source link for the latest updates.

TechnologyHacker News• 8m ago

1 points, 0 comments on Hacker News

FinanceSeeking Alpha• 10m ago

Developing story — details emerging. Check the source link for the latest updates.

FinanceBloomberg Markets• 12m ago

President Abelardo de la Espriella eased Colombia’s strict gun laws by lifting a general suspension of permits to carry firearms.